Integral Health Asset Management »

Arcellx shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Arcellx (ACLX) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Arcellx

Tip: Access up to 7 years of quarterly data

All positions including Arcellx held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcellx by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $18M 255k 69.55

More positions owned by Integral Health Asset Management

Viking Therapeutics Put Option (VKTX)
Insmed Com Par $.01 (INSM)
Tenet Healthcare Corp Com New (THC)
Boston Scientific Corporation (BSX)
Cytokinetics Com New (CYTK)
Merck & Co (MRK)
Encompass Health Corp (EHC)
Walgreen Boots Alliance (WBA)
Anthem (ELV)
Abbvie (ABBV)
Universal Hlth Svcs CL B (UHS)
Novartis Sponsored Adr (NVS)
Tarsus Pharmaceuticals (TARS)
Moonlake Immunotherapeutics Class A Ord Call Option (MLTX)
Longboard Pharmaceuticals In (LBPH)

View all positions for Integral Health Asset Management

Top funds holding Arcellx

FMR
Perceptive Advisors
Paradigm Biocapital Advisors
NEA Management Company
BlackRock
Sr One Capital Management
Vanguard Group
Henderson Group
State Street Corporation
T. Rowe Price Associates
RA Capital Management
Cormorant Asset Management
Suvretta Capital Management
T. Rowe Price Investment Management
Geode Capital Management

View all funds holding Arcellx